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Abstract 
A key objective of the British Thoracic Society national community acquired pneumonia (CAP) 
audit was to determine the clinical characteristics and outcomes of hospitalised adults given a 
primary discharge code of pneumonia but who did not fulfill accepted diagnostic criteria for 
pneumonia.  
 
Adults miscoded as having pneumonia (n=1251) were older compared to adults with CAP 
(n=6660) (median 80 years vs 78 years, p<0.001), and had more co-morbid disease, significantly 
fewer respiratory symptoms (fever, cough, dyspnoea, pleuritic pain), more constitutional 
symptoms (general deterioration, falls) and significantly lower 30-day in-patient mortality (14.3% 
vs 17.0%, adjusted Odds Ratio 0.75, p=0.003). 
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Introduction 
Clinical coding data are increasingly being used nationally to compare pneumonia related 
outcomes across institutions in the UK. Furthermore, data derived from pneumonia codes are 
used as a method for retrospectively identifying cases of community acquired pneumonia (CAP). 
However, considerable heterogeneity and variation in diagnostic and coding practices has been 
described across the UK.1  Possible reasons for observed variations in coding include local 
differences in coding practices and, specifically with regard to pneumonia, inherent difficulties in 
making a definitive diagnosis due to varied clinical presentations, lack of a diagnostic laboratory 
test and the limitations of chest X-rays (CXR). The extent of miscoding and misdiagnosis nationally 
and the effect of miscoding on reported patient outcomes are not known.  
 
The British Thoracic Society (BTS) conducted a national audit to compare the clinical 
characteristics and outcomes of adults miscoded as having pneumonia versus adults with CAP.  
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Methods 
Study design 
National Health Service (NHS) Institutions in England, Wales and Northern Ireland were invited 
to participate in the British Thoracic Society CAP audit for adults hospitalised to acute trusts 
between 1 December 2014 and 31 January 2015. Institutions were required to identify adult 
patients admitted over this period, with International Classification of Diseases (ICD)-10 primary 
discharge codes that included any of J12-J18. Medical notes of identified patients were reviewed 
by investigators at each participating site and entered into either one of two groups within the 
audit. Eligibility criteria for entry to the CAP group were: (a) age ≥ 16 years with new infiltrates 
on chest radiograph (determined by the auditing team), (b) presence of signs and symptoms of a 
lower respiratory tract infection (LRTI), (c) no hospital discharge within the preceding 10 days of 
index admission, and (d) not immunocompromised. All cases ineligible for inclusion to the CAP 
group were included in the non-CAP group.  Demographic and clinical data were extracted using 
a standardised pro-forma and entered onto a secure website. The BTS Quality Improvement 
Committee determined that ethical approval was not required for the conduct of this audit.  
 
Study population 
The CAP group comprised immunocompetent patients with a clinico-radiographic diagnosis of 
CAP as defined by accepted international criteria. Patients miscoded as having pneumonia 
comprised immunocompetent patients in the non-CAP group, who did not have nosocomial 
pneumonia; the latter defined as preceding hospitalisation within 10 days of index admission 
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with pneumonia or pneumonia arising during hospitalisation. For the comparative analysis, 
patients miscoded as having pneumonia were compared to those with CAP.   
 
Statistical considerations 
Statistical analyses was performed using Stata/IC 13.1 (©StataCorp., 2013). Pearson’s chi-
squared test was used to compare categorical variables. The Mann Whitney U-test was used to 
compare continuous variables. Baseline demographics and clinical features of adults with 
miscoded pneumonia were compared to those with CAP. The independent association between 
diagnosis (miscoded pneumonia or CAP) and 30-day in-patient (IP) mortality was examined using 
a multivariable logistic regression model. Likelihood ratio tests were used to determine the best 
fit of continuous variables and accordingly, age was fitted in the model as a categorical variable. 
Explanatory variables were examined to determine which co-variates were significantly 
associated (p≤0.05) with the outcome of 30-day IP mortality. Forward regression was 
subsequently conducted with the remaining co-variates; co-variates that led to a ≥10% change in 
the regression co-efficient between coded diagnosis and mortality were retained. A sensitivity 
analysis was performed to compare mortality in institutions that had submitted data for both the 
CAP and non-CAP groups.  
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Results 
Overall study population 
One hundred and fifty eight institutions submitted data towards the CAP group (n=6786), and 
115 institutions submitted data towards the non-CAP group (n=2211). In the CAP group, 30-day 
mortality data were missing in 126 cases, leaving 6660 patients for analysis. In the non-CAP 
group, data to determine immune status or treatment for nosocomial infection were unavailable 
for 278 patients and 30-day mortality data were missing in a further 7 patients; of the remaining 
1926 patients, 675 (35.0%) had nosocomial pneumonia and/or were immunocompromised, 
leaving 1251 (65.0%) patients who were miscoded as having pneumonia.  
 
Patients miscoded as having pneumonia 
Almost all patients miscoded as having pneumonia (1189 of 1251 (95.0%)) received antibiotic 
treatment on admission; 656 (55.2%) for treatment of presumed CAP, 373 (31.4%) for other 
lower respiratory tract infections (LRTIs) and 135 (11.4%) for other diagnoses. Symptoms 
consistent with a LRTI were present in 933 (74.6%) of miscoded patients at admission while the 
CXR was normal in 487 (38.9%) patients. Abnormal CXR findings included pleural effusions, 
cardiomegaly and chronic lung changes.  
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‘Miscoded pneumonia’ versus CAP  
Patients miscoded as having pneumonia were significantly older than those with CAP (median 80 
years vs 78 years, p<0.001). They were also significantly more likely to have major co-morbid 
conditions (0-1 co-morbidities, 61.3% vs 68.9%, 2-4 co-morbidities, 38.0% vs 30.6% and  ≥5 co-
morbidities 0.7% vs 0.5%; p for trend <0.001) including more  chronic heart disease (excluding 
hypertension), congestive heart failure, dementia, diabetes and cerebrovascular disease (Table 
1). Symptoms at presentation were significantly different between both groups; patients with 
miscoded pneumonia had significantly fewer respiratory symptoms including fever, cough, 
dyspnoea and pleuritic chest pain but significantly more non-specific constitutional symptoms 
including general deterioration, falls and altered conscious levels compared to those with CAP.  
 
Outcomes 
Patients with miscoded pneumonia were less likely to be admitted to critical care compared to 
patients with CAP (1.9% vs 5.1% respectively, OR 0.36, 95% CI 0.23-0.54, p<0.001), and had a 
lower 30-day IP mortality (14.3% vs 17.0% respectively, adjusted Odds Ratio (aOR) 0.75, 95% CI 
0.62-0.91, p=0.003; model adjusted for age, admission through emergency department, 
admission from a care home, co-morbid disease and critical care admission). 
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Discussion 
This is the first multi-centre analysis in the UK of hospitalised adults miscoded as having 
pneumonia. We found that such patients were older, had more co-morbid illnesses, fewer 
symptoms consistent with an acute respiratory infection and more non-specific constitutional 
symptoms at presentation compared to patients with clinico-radiographic evidence of CAP. 
Miscoded cases had a 25% lower odds of in-patient death at 30 days compared to those with CAP 
(similar mortality effect observed in sensitivity analysis; data not shown).   
 
Miscoding of pneumonia may occur because of coder-related error or physician-related 
misdiagnosis. Coder-related error mainly occurs during (1) data abstraction from medical notes 
or (2) interpretation of data for coding; coders may (a) assign generic codes when information 
exists for more specific codes (mis-specification error) or (b) re-sequence codes for a spell hence 
altering the primary diagnosis for that spell. In this study, 52% of patients miscoded as having 
pneumonia were treated as having CAP by their attending clinicians although on subsequent 
review these patients did not fulfill criteria for CAP; these constitute cases of miscoding due to 
misdiagnosis rather than coder-related error. This observation reflects the widely recognised 
difficulties with making an early diagnosis of pneumonia at the time of hospital admission based 
on clinical and chest radiographic features alone; non-pneumonic co-morbidities such as 
congestive heart failure may be misdiagnosed as pneumonia. Pressures to administer antibiotics 
as rapidly as possible in patients with CAP further increase the risk of misdiagnosis.  
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Many patients miscoded as having pneumonia had symptoms of an acute respiratory infection 
but did not have radiographic changes consistent with pneumonia. This clinical syndrome would 
be consistent with a diagnosis of acute bronchitis, as would the lower mortality observed in 
miscoded cases of pneumonia compared to patients with CAP.  In a community-based US study 
of elderly patients, a lower mortality in those with non-pneumonic LRTI compared to pneumonia 
was also observed (7% vs 13%), though no statistically significant difference was observed in a 
US study of hospitalised patients (8% vs 10%, p=0.09).2 3 The crude in-patient mortality of 14.3% 
in patients miscoded as having pneumonia is nevertheless high, underlining the vulnerability of 
older adults (mean age 80 years) with multiple comorbid illnesses to even non-pneumonic LRTIs. 
 
Strengths and limitations of this study 
Due to the study methodology, cases of CAP that were miscoded to an alternative diagnosis, such 
as LRTI, would not have been captured. However, there is no reason to expect this represents a 
large proportion of patients, nor for the characteristics of such patients to be different from 
patients correctly coded, as reported elsewhere.4 In particular, this limitation is not expected to 
have a significant impact on the comparative analysis.  
 
Studies of CT imaging in the investigation of patients admitted to hospital with suspected CAP 
have revealed the limitations of the CXR in identifying the full range of pneumonias.5. Therefore, 
it is possible that some cases in the ‘miscoded pneumonia’ group may have been misassigned 
based on a normal CXR (CT imaging may have revealed pneumonic changes). The effect of such 
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misclassification is that the observed differences between patients with CAP and those with 
‘miscoded pneumonia’ are likely to be conservative.  
 
The participation of a large number of NHS institutions across the UK is an important strength of 
this study. The findings from this study reflect current management and coding practices in 
relation to pneumonia in the NHS. 
 
Implications of this study 
Institutional variation in reported pneumonia outcomes derived from interrogation of clinical 
coding datasets may be confounded by variations in coding.  Efforts directed at measuring and 
reducing the degree of miscoding and misdiagnosis of pneumonia are needed if such datasets 
are to be used to assess quality improvement initiatives in pneumonia, or for high-level 
management purposes. At a clinical level, better diagnostics to help confidently identify patients 
with non-pneumonic conditions from among those presenting with suspected pneumonia may 
allow improved targeted treatment strategies and reduce unwarranted antibiotic use.  
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Table and figures 
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Table 1 - Baseline demographics, clinical characteristics and outcomes of hospitalised adults with miscoded pneumonia compared to those with CAP 
  Miscoded pneumonia group 
(n=1251) 
CAP group  
(n=6660) 
OR (95%CI) p value 
 
    
Age (years)¥ 80 (69-87) 78 (65-87) 1.01 (1.01-1.01) <0.001 
Male 585 (46.8) 3114 (46.8) 1.02 (0.91-1.16) 0.711 
Care home residentΔ 230 (18.8) 1044 (16.6) 1.17 (1.00-1.37) 0.057 
     
Admission route:      
         A&E 925 (73.9) 5030 (75.5) 0.90 (0.78-1.04) 0.142 
     
COMORBID DISEASE     
Congestive heart failure (CCF) 148 (11.8) 635 (9.5) 1.27 (1.05-1.54) 0.013 
Chronic obstructive pulmonary disease 
(COPD) 
279 (22.3) 1552 (23.3) 0.94 (0.82-1.09) 0.441 
Chronic lung disease (excluding COPD) 138 (11.0) 807 (12.1) 0.90 (0.74-1.09) 0.277 
Chronic heart diseases (excluding 
hypertension) 
328 (26.2) 1422 (21.4) 1.31 (1.14-1.50) <0.001 
Active malignancy 79 (6.3) 448 (6.7)  0.93 (0.73-1.20) 0.592 
Chronic renal disease 131 (10.5) 593 (8.9) 1.20 (0.98-1.46) 0.078 
Liver disease 10 (0.8) 47 (0.7) 1.13 (0.57-2.25) 0.719 
Dementia 207 (16.6) 609 (9.1) 1.97 (1.66-2.34) <0.001 
Diabetes 207 (16.6) 662 (9.9) 1.80 (1.52-2.13) <0.001 
Cerebrovascular disease 172 (13.8) 690 (10.4) 1.38 (1.15-1.65) <0.001 
     
Number of co-morbid diseases     
0-1 767 (61.3) 4589 (68.9) Reference <0.001Ɨ 
2-4 475 (38.0) 2040 (30.6) 1.39 (1.23-1.58)  
≥ 5 9 (0.7) 31 (0.5) 1.74 (0.82-3.66)  
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All values given as n (%) unless stated otherwise; ¥- median (IQR), † - p for trend 
 
    
CLINICAL FEATURES AT ADMISSION     
Respiratory symptoms     
Fever 473 (42.8)a 2953 (51.4)b 0.71 (0.62-0.81) <0.001 
Cough 839 (74.5)c 4887 (82.9)d 0.60 (0.52-0.70) <0.001 
Dyspnoea 747 (66.6)e 4629 (78.5)f 0.55 (0.48-0.63) <0.001 
Pleuritic chest pain 181 (17.8)g 1284 (24.9)h 0.65 (0.55-0.78) <0.001 
Wheeze  235 (24.6)i 1147 (23.9)j 1.04 (0.89-1.22) 0.629 
Haemoptysis 11 (0.9) 76 (1.1) 0.77 (0.41-1.45) 0.415 
     
Constitutional symptoms     
General deterioration from pre-morbid 
state 
67 (5.4) 263 (4.0) 1.38 (1.05-1.81) 0.022 
Altered consciousness 49 (3.9) 183 (2.8) 1.44 (1.05-1.99) 0.025 
Fall 132 (10.6) 465 (7.0) 1.57 (1.28-1.93) <0.001 
     
Abdominal symptoms* 61 (4.9) 253 (3.8) 1.30 (0.97-1.73) 0.073 
     
Severity features     
          Confusion 362 (28.9) 1648 (24.7) 1.52 (1.33-1.75) <0.001 
          Urea > 7 mmol/L 664 (53.1) 3235 (48.6) 1.29 (1.14-1.46) <0.001 
          Respiratory rate ≥ 30/min 156 (12.5) 1185 (17.8) 0.69 (0.57-0.82) <0.001 
          Blood pressure < 90  mmHg  
systolic and/or ≤ 60 mmHg 
diastolic 
321 (25.7) 1185 (17.8) 1.66 (1.44-1.92) <0.001 
     
OUTCOMES     
Critical care admission 24 (1.9) 340 (5.1) 0.36 (0.23-0.54) <0.001 
30-day IP mortality 179 (14.3) 1132 (17.0) 0.82 (0.69-0.97) 0.019 
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OR –Odds Ratio, 95% CI – 95% Confidence Interval 
Δ- Care home data available for 7523 adults in total 
Symptom data available for ‘n’ adults as described: a – n=1105; b –5746; c – 1126; d – 5893; e – 1122; f – 5899; g – 1016; h – 5157; i – 956; j 
– 4809   
*- composite of vomiting, diarrhea, abdominal pain and/or non-specific abdominal complaint  
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